MedWatch Safety Alerts

Duodenoscope Model TJF-Q180V by Olympus: FDA Safety Communication - New Reprocessing Instructions Validated

If not properly reprocessed patients may be exposed to serious infections.

Learn More

Mammograms at Richard D. Adelman M.D. in Raleigh, North Carolina: FDA Safety Communication - Quality Problems

The facility may not perform mammography due to the revocation of its accreditation.

Learn More

Hepatitis C Treatments Containing Sofosbuvir in Combination With Another Direct Acting Antiviral Drug: Drug Safety Communication - Serious Slowing of Heart Rate When Used With Antiarrhythmic Drug Amiodarone

Postmarketing cases of serious and life-threatening symptomatic bradycardia, as well as one fatal cardiac arrest and cases requiring pacemaker insertion, have been reported.

Learn More

Zyprexa Relprevv (olanzapine pamoate): Drug Safety Communication - FDA Review of Study Sheds Light on Two Deaths Associated with the Injectable Schizophrenia Drug

FDA is unable to exclude the possibility that the deaths were caused by rapid, but delayed, entry of the drug into the bloodstream following intramuscular injection.

Learn More

Over-the-Counter Asthma Products Labeled as Homeopathic: FDA Statement - Consumer Warning About Potential Health Risks

If asthma is not appropriately treated and managed, patients may be at risk for life-threatening asthma attacks.

Learn More

Lactated Ringer's Irrigation, 3000mL by Hospira: Recall - Mold Contamination

Contaminated solution used on a patient may result in bacteremia, sepsis, septic shock and endocarditis, and death may result.

Learn More

Treanda (bendamustine hydrochloride) Solution by Teva: FDA Statement - Not Compatible with Closed System Transfer Devices, Adapters, and Syringes Containing Polycarbonate or Acrylonitrile-Butadiene-Styrene

Can lead to device failure, possible product contamination, and potential serious adverse health consequences.

Learn More

Call us toll-free at (800) 641-0098